Research Advances on the Immunoregulatory Mechanisms and Targeted Therapy of the JAK-STAT Signaling Pathway in Allergic Rhinitis

Qiuye Wu; Jinjiang Xu; Man Zhang; Xiongbin Gui

doi:10.54097/jnghb665

Authors

Qiuye Wu
Jinjiang Xu
Man Zhang
Xiongbin Gui

DOI:

https://doi.org/10.54097/jnghb665

Keywords:

Allergic Rhinitis, JAK-STAT Signaling Pathway, Immunoregulatory

Abstract

Allergic rhinitis (AR) is a chronic airway disease characterized by immunoglobulin E (IgE)-mediated inflammation of the nasal mucosa, featuring complex pathogenesis where current therapeutic approaches remain insufficient to fully control symptoms and disease progression. The Janus kinase (JAK)/signal transduction and activator of transcription (STAT) pathway, a core signaling cascade ubiquitously expressed in cells, demonstrates multidimensional and multitargeted involvement in immunopathological processes of AR, including immune balance regulation, epithelial barrier impairment, and tissue remodeling. Recent advances reveal that JAK/STAT pathway-targeted inhibitors and herbal components exhibit therapeutic potential for AR by modulating Th1/Th2 immune imbalance, reducing mucus hypersecretion, and mitigating local inflammation. This review systematically summarizes the multidimensional regulatory network of the JAK/STAT pathway in AR and its targeted therapeutic strategies, aiming to provide theoretical foundations for elucidating AR pathogenesis, optimizing treatment approaches through immune microenvironment remodeling, and proposing novel insights for JAK/STAT-targeted therapeutic interventions.

Downloads

Download data is not yet available.

References

[1] Li Q, Zhang X, Feng Q, Zhou H, Ma C, Lin C, Wang D, Yin J. Common Allergens and Immune Responses Associated with Allergic Rhinitis in China. Journal of Asthma and Allergy 2023; Volume 16: 851-861.

[2] Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nature Reviews Disease Primers 2020; 6(1).

[3] Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, Luong A, Rodriguez K, Sedaghat AR, Toskala E, Villwock J, Abdullah B, Akdis C, Alt JA, Ansotegui IJ, Azar A, Baroody F, Benninger MS, Bernstein J, Brook C, Campbell R, Casale T, Chaaban MR, Chew FT, Chambliss J, Cianferoni A, Custovic A, Davis EM, DelGaudio JM, Ellis AK, Flanagan C, Fokkens WJ, Franzese C, Greenhawt M, Gill A, Halderman A, Hohlfeld JM, Incorvaia C, Joe SA, Joshi S, Kuruvilla ME, Kim J, Klein AM, Krouse HJ, Kuan EC, Lang D, Larenas-Linnemann D, Laury AM, Lechner M, Lee SE, Lee VS, Loftus P, Marcus S, Marzouk H, Mattos J, McCoul E, Melen E, Mims JW, Mullol J, Nayak JV, Oppenheimer J, Orlandi RR, Phillips K, Platt M, Ramanathan M, Jr., Raymond M, Rhee CS, Reitsma S, Ryan M, Sastre J, Schlosser RJ, Schuman TA, Shaker MS, Sheikh A, Smith KA, Soyka MB, Takashima M, Tang M, Tantilipikorn P, Taw MB, Tversky J, Tyler MA, Veling MC, Wallace D, Wang Y, White A, Zhang L. International consensus statement on allergy and rhinology: Allergic rhinitis - 2023. Int Forum Allergy Rhinol 2023; 13(4): 293-859.

[4] Jinesh S, Radhakrishnan R. Pharmaceutical aspects of JAK inhibitors: a comparative review. Inflammopharmacology 2025; 33(1): 91-104.

[5] Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular Targets for Biological Therapies of Severe Asthma. Front Immunol 2020; 11: 603312.

[6] Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 2014; 31: 31-37.

[7] Shamji MH, Sharif H, Layhadi JA, Zhu R, Kishore U, Renz H. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immunol 2022; 149(3): 791-801.

[8] Banafea GH, Bakhashab S, Alshaibi HF, Natesan Pushparaj P, Rasool M. The role of human mast cells in allergy and asthma. Bioengineered 2022; 13(3): 7049-7064.

[9] Duan S,Han XL,Li Y,Zhang L. Research on the expression of tight junctions on allergic rhinitis. Chinese Archives of Otolaryngology-Head and Neck Surgery 2021; 28(05): 293-296 (in Chinese).

[10] Shi Z, Jiang W, Wang M, Wang X, Li X, Chen X, Qiao L. Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis. Mol Cell Biochem 2017; 430(1-2): 161-169.

[11] Williams TC, Jackson DJ, Maltby S, Walton RP, Ching YM, Glanville N, Singanayagam A, Brewins JJ, Clarke D, Hirsman AG, Loo SL, Wei L, Beale JE, Casolari P, Caramori G, Papi A, Belvisi M, Wark PAB, Johnston SL, Edwards MR, Bartlett NW. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6. Am J Respir Cell Mol Biol 2021; 64(3): 344-356.

[12] Rossi GA, Ballarini S, Salvati P, Sacco O, Colin AA. Alarmins and innate lymphoid cells 2 activation: A common pathogenetic link connecting respiratory syncytial virus bronchiolitis and later wheezing/asthma? Pediatr Allergy Immunol 2022; 33(6): e13803.

[13] Ji T, Li H. T-helper cells and their cytokines in pathogenesis and treatment of asthma. Front Immunol 2023; 14: 1149203.

[14] Ishinaga H, Kitano M, Toda M, D'Alessandro-Gabazza CN, Gabazza EC, Shah SA, Takeuchi K. Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells. Cytokine 2017; 90: 60-65.

[15] Zhou Y, Chen R, Kong L, Sun Y, Deng J. Neuroimmune communication in allergic rhinitis. Front Neurol 2023; 14: 1282130.

[16] Larsson O, Tengroth L, Xu Y, Uddman R, Kumlien Georén S, Cardell LO. Substance P represents a novel first-line defense mechanism in the nose. J Allergy Clin Immunol 2018; 141(1): 128-136.e123.

[17] Sui P, Wiesner DL, Xu J, Zhang Y, Lee J, Van Dyken S, Lashua A, Yu C, Klein BS, Locksley RM, Deutsch G, Sun X. Pulmonary neuroendocrine cells amplify allergic asthma responses. Science 2018; 360(6393).

[18] Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 2021; 6(1): 402.

[19] Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 2023; 8(1): 204.

[20] Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, Ma H, Wei D, Sun S. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 2020; 80: 106210.

[21] Zhang S, Wu W, Gu M, Zhao Y, Wang L, Liu K, Yu Z. House dust mite induced mucosal barrier dysfunction and type 2 inflammatory responses via the MAPK/AP-1/IL-24 Signaling pathway in allergic rhinitis. Int Immunopharmacol 2025; 148: 113972.

[22] Bachus H, McLaughlin E, Lewis C, Papillion AM, Benveniste EN, Hill DD, Rosenberg AF, Ballesteros-Tato A, León B. IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling. Cell Mol Immunol 2023; 20(6): 651-665.

[23] Kausar S, Gul I, Liu R, Ke XX, Dong Z, Abbas MN, Cui H. Antheraea pernyi Suppressor of Cytokine Signaling 2 Negatively Modulates the JAK/STAT Pathway to Attenuate Microbial Infection. Int J Mol Sci 2022; 23(18).

[24] Klopfenstein N, Brandt SL, Castellanos S, Gunzer M, Blackman A, Serezani CH. SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense. PLoS Pathog 2021; 17(3): e1009387.

[25] Wu CS, Zou L. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation. J Biol Chem 2016; 291(1): 279-290.

[26] Pike KA, Tremblay ML. Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease. Front Immunol 2018; 9: 2504.

[27] Novosad J, Krčmová I, Souček O, Drahošová M, Sedlák V, Kulířová M, Králíčková P. Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment. Int J Mol Sci 2023; 24(6).

[28] Xu Z, Chu M. Advances in Immunosuppressive Agents Based on Signal Pathway. Front Pharmacol 2022; 13: 917162.

[29] Luo M, Jin T, Fang Y, Chen F, Zhu L, Bai J, Ding J. Signaling Pathways Involved in Acute Pancreatitis. J Inflamm Res 2025; 18: 2287-2303.

[30] Howell MD, Kuo FI, Smith PA. Targeting the Janus Kinase Family in Autoimmune Skin Diseases. Front Immunol 2019; 10: 2342.

[31] Zhang H, Li X, Liu YL, Liu WJ, Wang Y, Bai HT, Zhang JX, Su FY, Yuan FL, Li L, Meng GY, Zheng RX, Zhang Y. miR-148a-3p inhibits Th1 cell polarization via down-regulating IL-12/IL-12Rβ1/IL-12Rβ2/IFN-γ pathway. Chinese Journal of Pharmacology and Toxicology 2021; 35(11): 816-823 (in Chinese).

[32] Wang L, Deng Z, Sun Y, Zhao Y, Li Y, Yang M, Yuan R, Liu Y, Qian Z, Zhou F, Kang H. The Study on the Regulation of Th Cells by Mesenchymal Stem Cells Through the JAK-STAT Signaling Pathway to Protect Naturally Aged Sepsis Model Rats. Front Immunol 2022; 13: 820685.

[33] Lindén A, Dahlén B. Interleukin-17 cytokine signalling in patients with asthma. Eur Respir J 2014; 44(5): 1319-1331.

[34] Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol 2012; 8(2): 161-168.

[35] Xu W, Shu JH, Gan Y, Tu DN. Research advances in the regulatory mechanism of immune balance between Th17 and Treg cells. China Journal of Modern Medicine 2023; 33(24): 48-54 (in Chinese).

[36] Alvarez F, Istomine R, Shourian M, Pavey N, Al-Aubodah TA, Qureshi S, Fritz JH, Piccirillo CA. The alarmins IL-1 and IL-33 differentially regulate the functional specialisation of Foxp3(+) regulatory T cells during mucosal inflammation. Mucosal Immunol 2019; 12(3): 746-760.

[37] Dikiy S, Li J, Bai L, Jiang M, Janke L, Zong X, Hao X, Hoyos B, Wang ZM, Xu B, Fan Y, Rudensky AY, Feng Y. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance. Immunity 2021; 54(5): 931-946.e911.

[38] Moura RA, Fonseca JE. JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis. Front Med (Lausanne) 2020; 7: 607725.

[39] Saadatdoust Z, Pandurangan AK, Ananda Sadagopan SK, Mohd Esa N, Ismail A, Mustafa MR. Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway. J Nutr Biochem 2015; 26(12): 1547-1558.

[40] Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, Arkwright PD, Kreins AY, Averbuch D, Engelhard D, Magdorf K, Kilic SS, Minegishi Y, Nonoyama S, French MA, Choo S, Smart JM, Peake J, Wong M, Gray P, Cook MC, Fulcher DA, Casanova JL, Deenick EK, Tangye SG. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 2012; 119(17): 3997-4008.

[41] Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs 2017; 77(11): 1261.

[42] Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B. STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis. Bioimpacts 2025; 15: 30030.

[43] Yamasaki A, Saleh A, Koussih L, Muro S, Halayko AJ, Gounni AS. IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS One 2010; 5(2): e9178.

[44] Wang HY, Huang HY, Liu XL. The relationship between CCL8 related pathways and allergic diseases. Chemistry of Life 2021; 41(10): 2119-2124 (in Chinese).

[45] Cheng L, Chen J, Fu Q, He S, Li H, Liu Z, Tan G, Tao Z, Wang D, Wen W, Xu R, Xu Y, Yang Q, Zhang C, Zhang G, Zhang R, Zhang Y, Zhou B, Zhu D, Chen L, Cui X, Deng Y, Guo Z, Huang Z, Huang Z, Li H, Li J, Li W, Li Y, Xi L, Lou H, Lu M, Ouyang Y, Shi W, Tao X, Tian H, Wang C, Wang M, Wang N, Wang X, Xie H, Yu S, Zhao R, Zheng M, Zhou H, Zhu L, Zhang L. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res 2018; 10(4): 300-353.

[46] Morales JK, Falanga YT, Depcrynski A, Fernando J, Ryan JJ. Mast cell homeostasis and the JAK-STAT pathway. Genes Immun 2010; 11(8): 599-608.

[47] Chang TM, Hsiao TC, Yang TY, Huang HC. IgE-Induced Mast Cell Activation Is Suppressed by Dihydromyricetin through the Inhibition of NF-κB Signaling Pathway. Molecules 2021; 26(13).

[48] Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol 2003; 284(4): G646-654.

[49] Zhang XX, Wu GP. Advances in the structure and effect mechanism study of nasal mucosal barrier. International Journal of Otolaryngology-Head and Neck Surgery 2023; 47(02): 82-86 (in Chinese).

[50] Lin YT, Chen WC, Tsai MH, Chen JY, Chien CY, Huang SC. JAK2 Phosphorylation Signals and Their Associated Cytokines Involved in Chronic Rhinosinusitis with Nasal Polyps and Correlated with Disease Severity. Biomolecules 2021; 11(7).

[51] Song L, Zhu ZJ, Xu QR, Lu XJ, Dong JJ. Study on the protective effect of loratadine on allergic rhinitis rats based on IL-6/JAK2/STAT3 signaling pathway. Journal of Tropical Medicine 2020; 20(06): 735-740+716 (in Chinese).

[52] Xie X, Wang P, Jin M, Wang Y, Qi L, Wu C, Guo S, Li C, Zhang X, Yuan Y, Ma X, Liu F, Liu W, Liu H, Duan C, Ye P, Li X, Borish L, Zhao W, Feng X. IL-1β-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps. Nat Commun 2024; 15(1): 9101.

[53] Ingram JL, Antao-Menezes A, Mangum JB, Lyght O, Lee PJ, Elias JA, Bonner JC. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J Immunol 2006; 177(6): 4141-4148.

[54] Liu S, Chen L, Shang Y. CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway. Redox Rep 2025; 30(1): 2444755.

[55] Lu J, Zhu Y, Feng W, Pan Y, Li S, Han D, Liu L, Xie X, Wang G, Li M. Platelet-derived growth factor mediates interleukin-13-induced collagen I production in mouse airway fibroblasts. J Biosci 2014; 39(4): 693-700.

[56] Sahnoon L, Bajbouj K, Mahboub B, Hamoudi R, Hamid Q. Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma. Clin Rev Allergy Immunol 2025; 68(1): 44.

[57] Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, Rückert B, Globinska A, Jakiela B, Kast JI, Idzko M, Akdis M, Sanak M, Akdis CA. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol 2017; 139(1): 93-103.

[58] Büttner C, Skupin A, Rieber EP. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 2004; 198(2): 248-258.

[59] Du MZ, Shen JL, Wu Q, Hu XY, Chu DY. Inhibitory Effect of Paeoniflorin on the Collagen Production by Fibroblasts through IL-13/STAT6 Signaling Pathway. Chinese Journal of Parasitology and Parasitic Diseases 2011; 29(02): 93-98 (in Chinese).

[60] Braithwaite IE, Cai F, Tom JA, Galanter JM, Owen RP, Zhu R, Williams M, McGregor AG, Eliahu A, Durk MR, Dengler HS, Zak M, Kenny JR, Wilson ME, Beasley R, Chen H. Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial. J Allergy Clin Immunol 2021; 148(3): 783-789.

[61] Yan F, Li W, Zhou H, Wu Y, Ying S, Chen Z, Shen H. Interleukin-13-induced MUC5AC expression is regulated by a PI3K-NFAT3 pathway in mouse tracheal epithelial cells. Biochem Biophys Res Commun 2014; 446(1): 49-53.

[62] Zimmer J, Weitnauer M, Boutin S, Küblbeck G, Thiele S, Walker P, Lasitschka F, Lunding L, Orinska Z, Vock C, Arnold B, Wegmann M, Dalpke A. Nuclear Localization of Suppressor of Cytokine Signaling-1 Regulates Local Immunity in the Lung. Front Immunol 2016; 7: 514.

[63] Metz M, Kolkhir P, Altrichter S, Siebenhaar F, Levi-Schaffer F, Youngblood BA, Church MK, Maurer M. Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases. Allergy 2024; 79(1): 37-51.

[64] Chen XQ, Ma HA, Zhou LY, Yan DN, Liu SF, Wu JY. Preliminary Study on the Improvement Effects of Astragaloside Ⅳ on Allergic Rhinitis Model Mice. China Pharmacy 2021; 32(10): 1187-1195 (in Chinese).

[65] Ren M, Wang Y, Lin L, Li S, Ma Q. α-Linolenic Acid Screened by Molecular Docking Attenuates Inflammation by Regulating Th1/Th2 Imbalance in Ovalbumin-Induced Mice of Allergic Rhinitis. Molecules 2022; 27(18).

[66] Ren MY, Xiao Y, Tang MW, Wang M. Effects and Immunomodulatory Mechanisms of Chuanxiong Chatiao San on Allergic Rhinitis Model Mice. Chinese Traditional Patent Medicine 2022; 44(12): 4014-4018 (in Chinese).